214 related articles for article (PubMed ID: 2290957)
1. Improvements in MPTP-induced object retrieval deficits and behavioral deficits after fetal nigral grafting in monkeys.
Taylor JR; Elsworth JD; Roth RH; Collier TJ; Sladek JR; Redmond DE
Prog Brain Res; 1990; 82():543-59. PubMed ID: 2290957
[TBL] [Abstract][Full Text] [Related]
2. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls.
Taylor JR; Elsworth JD; Roth RH; Sladek JR; Collier TJ; Redmond DE
Exp Brain Res; 1991; 85(2):335-48. PubMed ID: 1893983
[TBL] [Abstract][Full Text] [Related]
3. Early gestational mesencephalon grafts, but not later gestational mesencephalon, cerebellum or sham grafts, increase dopamine in caudate nucleus of MPTP-treated monkeys.
Elsworth JD; Sladek JR; Taylor JR; Collier TJ; Redmond DE; Roth RH
Neuroscience; 1996 May; 72(2):477-84. PubMed ID: 8737417
[TBL] [Abstract][Full Text] [Related]
4. Sham surgery does not ameliorate MPTP-induced behavioral deficits in monkeys.
Taylor JR; Elsworth JD; Sladek JR; Collier TJ; Roth RH; Redmond DE
Cell Transplant; 1995; 4(1):13-26. PubMed ID: 7728327
[TBL] [Abstract][Full Text] [Related]
5. Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys.
Elsworth JD; Brittan MS; Taylor JR; Sladek JR; al-Tikriti MS; Zea-Ponce Y; Innis RB; Redmond DE; Roth RH
Cell Transplant; 1996; 5(2):315-25. PubMed ID: 8689042
[TBL] [Abstract][Full Text] [Related]
6. Fetal nondopaminergic neural implants in parkinsonian primates. Histochemical and behavioral studies.
Bankiewicz KS; Plunkett RJ; Jacobowitz DM; Kopin IJ; Oldfield EH
J Neurosurg; 1991 Jan; 74(1):97-104. PubMed ID: 1670609
[TBL] [Abstract][Full Text] [Related]
7. Parkinsonian monkeys with prior levodopa-induced dyskinesias followed by fetal dopamine precursor grafts do not display graft-induced dyskinesias.
Kordower JH; Vinuela A; Chu Y; Isacson O; Redmond DE
J Comp Neurol; 2017 Feb; 525(3):498-512. PubMed ID: 27418401
[TBL] [Abstract][Full Text] [Related]
8. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
[TBL] [Abstract][Full Text] [Related]
9. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model.
Nikkhah G; Duan WM; Knappe U; Jödicke A; Björklund A
Neuroscience; 1993 Sep; 56(1):33-43. PubMed ID: 8232915
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study.
Elsworth JD; Brittan MS; Taylor JR; Sladek JR; Redmond DE; Innis RB; Zea-Ponce Y; Roth RH
Brain Res; 1998 Jun; 795(1-2):55-62. PubMed ID: 9622593
[TBL] [Abstract][Full Text] [Related]
11. Behavioral recovery from MPTP-induced parkinsonism in monkeys after intracerebral tissue implants is not related to CSF concentrations of dopamine metabolites.
Bankiewicz KS; Plunkett RJ; Mefford I; Kopin IJ; Oldfield EH
Prog Brain Res; 1990; 82():561-71. PubMed ID: 1705356
[No Abstract] [Full Text] [Related]
12. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
[TBL] [Abstract][Full Text] [Related]
13. Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey.
Starr PA; Wichmann T; van Horne C; Bakay RA
Cell Transplant; 1999; 8(1):37-45. PubMed ID: 10338274
[TBL] [Abstract][Full Text] [Related]
14. Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats.
Palmer MR; Granholm AC; van Horne CG; Giardina KE; Freund RK; Moorhead JW; Gerhardt GA
Brain Res; 2001 Jan; 890(1):86-99. PubMed ID: 11164771
[TBL] [Abstract][Full Text] [Related]
15. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies.
Kordower JH; Rosenstein JM; Collier TJ; Burke MA; Chen EY; Li JM; Martel L; Levey AE; Mufson EJ; Freeman TB; Olanow CW
J Comp Neurol; 1996 Jun; 370(2):203-30. PubMed ID: 8808731
[TBL] [Abstract][Full Text] [Related]
16. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway.
Annett LE; Martel FL; Rogers DC; Ridley RM; Baker HF; Dunnett SB
Exp Neurol; 1994 Feb; 125(2):228-46. PubMed ID: 7906227
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
[TBL] [Abstract][Full Text] [Related]
18. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM
Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival of grafted cells, dopamine synthesis/release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway.
Nishino H; Hashitani T; Kumazaki M; Sato H; Furuyama F; Isobe Y; Watari N; Kanai M; Shiosaka S
Brain Res; 1990 Nov; 534(1-2):83-93. PubMed ID: 1981488
[TBL] [Abstract][Full Text] [Related]
20. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ
Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
